UnitedHealth Group Incorporated (NYSE:UNH) Holdings Trimmed by Schnieders Capital Management LLC

Schnieders Capital Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,466 shares of the healthcare conglomerate’s stock after selling 612 shares during the period. UnitedHealth Group accounts for 1.4% of Schnieders Capital Management LLC’s investment portfolio, making the stock its 18th biggest holding. Schnieders Capital Management LLC’s holdings in UnitedHealth Group were worth $6,812,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Apriem Advisors acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $384,000. Nwam LLC boosted its stake in shares of UnitedHealth Group by 4.5% during the 4th quarter. Nwam LLC now owns 4,386 shares of the healthcare conglomerate’s stock valued at $2,219,000 after buying an additional 188 shares during the period. GenTrust LLC boosted its stake in shares of UnitedHealth Group by 2.5% during the 4th quarter. GenTrust LLC now owns 2,375 shares of the healthcare conglomerate’s stock valued at $1,201,000 after buying an additional 57 shares during the period. Heritage Investors Management Corp lifted its stake in shares of UnitedHealth Group by 1.9% in the 4th quarter. Heritage Investors Management Corp now owns 68,313 shares of the healthcare conglomerate’s stock valued at $34,557,000 after purchasing an additional 1,262 shares during the last quarter. Finally, Whipplewood Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $625,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on UNH shares. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Performance

UNH stock opened at $463.69 on Thursday. The business’s fifty day moving average is $517.50 and its 200-day moving average is $558.41. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $426.73 billion, a P/E ratio of 29.92, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.83 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.